Status:
COMPLETED
Uric Acid and Long-term Outcomes in Chronic Kidney Disease
Lead Sponsor:
Tufts Medical Center
Collaborating Sponsors:
Takeda Pharmaceuticals North America, Inc.
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
18-70 years
Brief Summary
Patients in the earlier stages of Chronic kidney disease (CKD) are at risk both for the development of end-stage renal disease (ESRD) (define by the requirement for dialysis or kidney transplantation)...
Eligibility Criteria
Inclusion
- between 18 and 70 years of age
- with serum creatinine of 1.2 to 7 mg/dl in women and 1.4 to 7 mg/dl in men
Exclusion
- pregnancy
- Type I diabetes
- insulin dependent type II diabetes
- renal artery stenosis
- proteinuria greater than 10mg/day
- mean arterial pressure greater than 125 mmHg
- prior kidney transplant
Key Trial Info
Start Date :
February 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
838 Patients enrolled
Trial Details
Trial ID
NCT01158911
Start Date
February 1 2007
Last Update
July 8 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tufts Medical Center
Boston, Massachusetts, United States, 02111